FDA Inspection 1163560 — Saint Luke's Hospital Of Kansas City
The FDA completed an inspection of Saint Luke's Hospital Of Kansas City on Feb 28, 2022 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 28, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kansas City, MO (United States)